Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. Tocris Bioscience™ AZD 1283

Tocris Bioscience™ AZD 1283
GREENER_CHOICE

Catalog No. 608550
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
60-855-0 50 mg
60-851-0 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 60-855-0 Supplier Tocris Bioscience™ Supplier No. 6085/50
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

High affinity P2Y12 antagonist

AZD 1283 is a potent and high affinity P2Y12 antagonist (IC50 = 11 nM in radioligand competition binding assay, and 25 nM in a GTPγS binding assay). Causes a dose-dependent increase in blood flow and inhibits ADP-induced platelet aggregation in vivo. Antithrombotic.

Specifications

Chemical Name or Material Ethyl 5-cyano-2-methyl-6-[4-[[[(phenylmethyl)sulfonyl]amino]carbonyl]-1-piperidinyl]-3-pyridinecarboxylate
CAS 919351-41-0
Synonym Ethyl 5-cyano-2-methyl-6-[4-[[[(phenylmethyl)sulfonyl]amino]carbonyl]-1-piperidinyl]-3-pyridinecarboxylate
Quantity 50 mg
Solubility Soluble to 100mM in DMSO
Target P2Y Receptor Antagonists
Molecular Formula C23H26N4O5S
Formula Weight 470.54
Physical Form Solid
Color White
Product Type Bioactive Small Molecule
Purity 98%
Show More Show Less

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.